
Chinook Therapeutics KDNY
Quartalsbericht 2023-Q2
hinzugefügt 16.05.2026
Chinook Therapeutics Kurzfristige Verbindlichkeiten 2011-2026 | KDNY
Kurzfristige Verbindlichkeiten Jährlich Chinook Therapeutics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 50.8 M | 40.1 M | 22.8 M | 2.43 M | 30.5 M | 41.4 M | 30.6 M | 31.1 M | 44.2 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 50.8 M | 2.43 M | 32.7 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Happiness Biotech Group Limited
HAPP
|
6.4 M | - | 1.35 % | $ 17.8 M | ||
|
AgeX Therapeutics
AGE
|
3.56 M | - | -10.17 % | $ 12.2 K | ||
|
Coherus BioSciences
CHRS
|
140 M | $ 1.72 | 4.57 % | $ 201 M | ||
|
I-Mab
IMAB
|
576 M | - | - | $ 866 M | ||
|
Celldex Therapeutics
CLDX
|
51 M | $ 31.9 | 3.39 % | $ 2.12 B | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
1.62 B | - | - | $ 40.3 B | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
1.77 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
47.5 M | - | - | $ 269 M | ||
|
Compugen Ltd.
CGEN
|
22.6 M | $ 2.68 | 0.75 % | $ 250 M | ||
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | ||
|
Enlivex Therapeutics Ltd.
ENLV
|
9.02 M | $ 0.75 | 9.37 % | $ 34.3 M | ||
|
Esperion Therapeutics
ESPR
|
301 M | $ 3.13 | 0.32 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
38.5 M | $ 31.76 | 1.5 % | $ 855 M | ||
|
Forte Biosciences
FBRX
|
20.8 M | $ 22.94 | 4.54 % | $ 297 M | ||
|
Институт стволовых клеток человека
ISKJ
|
556 M | - | - | - | ||
|
Checkmate Pharmaceuticals
CMPI
|
9.38 M | - | - | $ 231 M | ||
|
Berkeley Lights
BLI
|
45.5 M | - | -7.31 % | $ 87 M | ||
|
Generation Bio Co.
GBIO
|
35.1 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
39.8 M | - | - | $ 3.67 B | ||
|
Akouos
AKUS
|
16.8 M | - | 0.23 % | $ 488 M | ||
|
Ayala Pharmaceuticals
AYLA
|
7.54 M | - | - | $ 7.46 M | ||
|
Hutchison China MediTech Limited
HCM
|
316 M | $ 11.93 | 1.53 % | $ 10.2 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.33 M | - | -4.36 % | $ 27 M | ||
|
Freeline Therapeutics Holdings plc
FRLN
|
31 M | - | - | $ 384 M | ||
|
Heron Therapeutics
HRTX
|
96.1 M | $ 0.92 | 3.78 % | $ 153 M | ||
|
Gracell Biotechnologies
GRCL
|
221 M | - | - | $ 3.37 B | ||
|
Anika Therapeutics
ANIK
|
21.9 M | $ 14.69 | -1.36 % | $ 211 M | ||
|
Advaxis
ADXS
|
25 M | - | -9.65 % | $ 45.9 M | ||
|
Aeglea BioTherapeutics
AGLE
|
58.7 M | - | - | $ 1.01 B | ||
|
Applied Genetic Technologies Corporation
AGTC
|
25.2 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
1.61 M | - | 1.93 % | $ 17.4 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
2.73 M | $ 3.42 | -0.73 % | $ 5.63 M | ||
|
Aptose Biosciences
APTO
|
9.31 M | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
6.29 M | - | -39.0 % | $ 4.57 M | ||
|
Albireo Pharma
ALBO
|
45.3 M | - | -0.23 % | $ 916 M |